CANY
ZVRA icon

Caxton Associates (New York)’s Zevra Therapeutics ZVRA Stock Holding History

Caxton Associates (New York)’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,027
Closed -$201K – 713
2021
Q4 		$201K Buy
+23,027
New +$201K 0.02% 466